Skip to main content
Premium Trial:

Request an Annual Quote

Syzygy Biotech Nabs $100K Investment for PCR Reagent Development


This article has been corrected from a previous version to correct misinformation regarding the current name of Syzygy Biotech.

Syzygy Biotech, a Grand Rapids, Mich.-based PCR reagents shop, has received a $100,000 investment from the Michigan Pre-Seed Capital Fund, fund administrator Ann Arbor Spark said today.

Syzygy, which was formed under the name Seedus Biotech, manufactures low-cost reagents such as Taq polymerases and master mixes for use in DNA amplification.

According to its website, the company is also currently developing a high-fidelity polymerase that it claims combines Taq's ease of use with equal or greater replication accuracy.

Syzygy is one of several companies to have recently received investments totaling about $1.8 million from the Michigan Pre-Seed Capital Fund, an equity fund administered by Ann Arbor Spark that invests in technology-based companies to support business formation and acceleration.

Last month, Syzygy also won a $100,000 SmartZone award at the Great Lakes Entrepreneur's Quest business plan contest held at Michigan State University. That award was also funded through the Michigan Pre-Seed Capital Fund.

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.